rss
Help

Adaptation to Human Populations Is Revealed by Within-Host Polymorphisms in HIV-1 and Hepatitis C Virus

5212 views
|
DOI: 10.4016/2755.01
|
login to rate  
URL
Embed
| More
  1. Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C (2005) Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 79: 13239-13249.
  2. Bowen DG, Walker CM (2005) Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436: 946-952.
  3. Klein J (1986) . Natural history of the major histocompatibility complexWiley. New York.
  4. Pircher H, Moskkophidis D, Rohrer U, Bürki K, Hengartner H (1990) Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346: 629-633.
  5. Yusim K, Kesmir C, Gaschen B, Addo MM, Altfeld M (2002) Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 76: 8757-8768.
  6. Fernandez CS, Stratov I, De Rose R, Walsh K, Dale CJ (2005) Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J Virol 79: 5721-5731.
  7. Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R (2004) Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nature Med 10: 275-281.
  8. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nature Med 10: 282-289.
  9. Moore CB, John M, James IR, Christiansen FT, Witt CS (2002) Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296: 1439-1443.
  10. Ross HA, Rodrigo AG (2002) Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J Virol 76: 11715-11720.
  11. Gaudieri S, Rauch A, Park LP, Freitas E, Herrmann S (2006) Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J Virol 80: 11094-11104.
  12. Trachtenberg E, Korber B, Sollars C, Kepler TB, Hraber PT (2003) Advantage of a rare HLA supertype in HIV disease progression. Nature Med 9: 928-935.
  13. Goulder P, Brander C, Tang YH, Tremblay C, Colbert RA (2001) Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412: 334-338.
  14. Barouch DH, Powers J, Truitt DM, Kishko MG, Arthur JC (2005) Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nature Immunol 6: 247-252.
  15. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D (1999) Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73: 10489-502.
  16. Rouzine IM, Coffin JM (1999) Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus. J Virol 73: 8167-8178.
  17. Kimura M (1968) Evolutionary rate at the molecular level. Nature 217: 624-626.
  18. Hudson RR, Kreitman M, Aguadé M (1987) A test of neutral molecular evolution based on nucleotide data. Genetics 116: 153-159.
  19. Williamson S (2003) Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol Biol Evol 20: 1318-1325.
  20. Smith NGC, Eyre-Walker A (2002) Adaptive protein evolution in Drosophila. Nature 415: 1022-1024.
  21. Larder BA, Kohli A, Kellam P, Kemp SD, Kronick M (1993) Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing. Nature 365: 671-673.
  22. Leitner T, Halapi E, Scarlatti G, Rossi P, Albert J (1993) Analysis of heterogeneous viral populations by direct DNA-sequencing. Biotechniques 15: 120-127.
  23. Schuurman R, Demeter L, Reichelderfer P, Tijnagel J, de Groot T (1999) Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J Clin Microbiol 37: 2291-2296.
  24. Grenfell BT, Pybus OG, Gog JR, Wood JLN, Daly JM (2004) Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303: 327-332.
  25. Kelly JK, Williamson S, Orive ME, Smith MS, Holt RD (2003) Linking dynamical and population genetic models of persistent viral infection. Am Nat 162: 14-28.
  26. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 57: 289-300.
  27. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 769-774.
  28. John M, Mallal S (2005) CTL responses to HIV and SIV: Wrestling with smoke. Nature Immunol 6: 232-234.
  29. Moran PAP (1962) . The statistical processes of evolutionary theoryClarendon Press. Oxford.
  30. Felsenstein J (1976) The theoretical population genetics of variable selection and migration. Ann Rev Genet 10: 253-280.
  31. Crow JF, Kimura M (1970) . An introduction to population genetics theoryHarper and Row. New York.
  32. Leigh Brown AJ (1997) Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc Natl Acad Sci USA 94: 1862-1865.
  33. Nijhuis M, Boucher CAB, Schipper P, Leitner T, Schuurman R (1998) Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc Natl Acad Sci USA 95: 14441-14446.
  34. Achaz G, Palmer S, Kearney M, Maldarelli F, Mellors JW (2004) A robust measure of HIV-1 population turnover within chronically infected individuals. Mol Biol Evol 21: 1902-1912.
  35. Bonhoeffer S, Holmes EC, Nowak MA (1995) Causes of HIV diversity. Nature 376: 125.
  36. Liu SL, Schacker T, Musey L, Shriner D, McElrath MJ (1997) Divergent patterns of progression to AIDS after infection from the same source: Human immunodeficiency virus type 1 evolution and antiviral responses. J Virol 71: 4284-4295.
  37. Yamaguchi Y, Gojobori T (1997) Evolutionary mechanisms and population dynamics of the third variable region of HIV within single hosts. Proc Natl Acad Sci USA 94: 1264-1269.
  38. Yamaguchi-Kabata Y, Gojobori T (2000) Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes. J Virol 74: 4335-4350.
  39. Chen L, Perlina A, Lee CJ (2004) Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase. J Virol 78: 3722-3732.
  40. Simmonds P, Balfe P, Ludlam C, Bishop J, Leigh Brown A (1990) Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol 64: 5840-5850.
  41. Seibert SA, Howell CY, Hughes MK, Hughes AL (1995) Natural selection on the gag, pol, and env genes of human immunodeficiency virus 1 (HIV-1). Mol Biol Evol 12: 803-813.
  42. Nielsen R, Yang Z (1998) Likelihood methods for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148: 929-936.
  43. Crandall KA, Kelsey CR, Imamichi H, Lane HC, Salzman NP (1999) Parallel evolution of drug resistance in HIV: Failure of nonsynonymous/synonymous substitution rate ratio to detect selection. Mol Biol Evol 16: 372-382.
  44. Cichutek K, Merget H, Norley S, Linde R, Kreuz W (1992) Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc Natl Acad Sci USA 89: 7365-7369.
  45. Wolfs TFW, Zwart W, Bakker M, Goudsmit J (1992) HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189: 103-110.
  46. McDonald RA, Mayers DL, Chung RC, Wagner KF, Ratto-Kim S (1997) Evolution of human immunodefiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function. J Virol 71: 1871-1879.
  47. Zanotto PMA, Kallas EG, de Souza RF, Holmes EC (1999) Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 153: 1077-1089.
  48. Kosakovsky Pond SL, Frost SDW, Grossman Z, Gravenor MB, Richman DD (2006) Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol 2: e62doi:10.1371/journal.pcbi.0020062.
  49. Ferguson NM, Galvani AP, Bush RM (2003) Ecological and immunological determinants of influenza evolution. Nature 422: 428-433.
  50. Rhee SY, Gonzales MJ, Kantor R, Betts BJ, Jaideep R (2003) Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucl Acids Res 31: 298-303.
  51. Leitner T, Korber B, Daniels M, Calef C, Foley B (2005) HIV-1 subtype and circulating recombinant form (CRF) reference sequences, 2005. HIV Sequence Compendium 2005Los Alamos National Laboratory. Los Alamos (New Mexico)In:.
  52. Kosakovsky Pond SL, Frost SDW, Muse SV (2005) HyPhy: Hypothesis testing using phylogenies. Bioinformatics 21: 676-679.
  53. Ewing B, Hillier L, Wendl MC, Green P (1998) Base-calling of automated sequencer traces using Phred. I. Accuracy assessment. Genome Res 8: 175-185.
  54. Alfonso V, Flichman DM, Sookoian S, Mbayed VA, Campos RH (2004) Evolutionary study of HVR1 of E2 in chronic hepatitis C virus infection. J Gen Virol 85: 39-46.
  55. Ben Othman S, Bouzgarrou N, Achour A, Bourlet T, Pozzetto B (2004) High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre of Tunisia. Pathol Biol 52: 323-327.
  56. Nicot F, Legrand-Abravanel F, Sandres-Saune K, Boulestin A, Dubois M (2005) Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J Gen Virol 86: 107-114.
  57. Pasquier C, Njouom R, Ayouba A, Dubois M, Sartre MT (2005) Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol 77: 390-398.
  58. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res 22: 4673-4680.
  59. Rambaut A (1996) . Se-Al: Sequence alignment editorAvailable: http://evolve.zoo.ox.ac.uk. Accessed 27 February 2007..
  60. Saitou N, Nei M (1987) The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
  61. Tamura K, Nei M (1993) Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10: 512-526.
  62. Suzuki Y, Gojobori T (1999) A method for detecting positive selection at single amino acid sites. Mol Biol Evol 16: 1315-1328.
  63. Kosakovsky Pond SL, Frost SDW (2005) Not so different after all: A comparison of methods for detecting amino acid sites under selection. Mol Biol Evol 22: 1208-1222.
  64. Korber BTM, Brander C, Haynes BF, Koup R, Moore JP (2005) . HIV Molecular Immunology 2005Los Alamos National Laboratory. Los Alamos (New Mexico).
  65. Yusim K, Richardson R, Tao N, Szinger J, Funkhouser R (2005) The Los Alamos hepatitis C immunology database. Appl Bioinformatics 4: 217-225.
  66. Moran PAP (1958) Random processes in genetics. Math Proc Camb Phil Soc 54: 60-71.
Please describe the reason for abuse:
Supplementary Materials
Comments